ELDN

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

02/07 11:00 am

4 High-Risk, High-Reward Small-Cap Stocks to Play the Rotation - Investing.com

07/24 08:36 am

Are Medical Stocks Lagging DaVita (DVA) This Year?

06/26 09:40 am

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

06/03 04:01 pm

Eledon Pharmaceuticals (ELDN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

05/27 09:55 am

Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy?

05/22 12:00 pm

Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade

05/14 12:00 pm

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

05/09 07:30 am

Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

05/07 03:40 pm

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

05/07 07:05 am

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

03/28 04:01 pm

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

03/25 04:56 pm

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

03/21 10:31 am

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/13 08:01 pm

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

01/04 05:40 pm

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12/04 07:00 pm

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

11/29 05:05 pm

Expert Ratings for Eledon Pharma

11/13 11:00 am

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

11/09 05:01 pm

Eledon Pharmaceuticals, Inc. (ELDN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

11/09 10:55 am

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

11/08 05:05 pm

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

11/02 09:05 am

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

10/23 07:00 am

Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting

10/13 07:00 am

Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

10/02 07:00 am

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023

09/27 11:00 am

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

09/25 07:00 am

Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

09/20 04:05 pm

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

09/11 07:00 am

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference

06/02 08:00 am

Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

06/01 07:55 am

Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology

03/31 06:00 am

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results

03/30 04:01 pm

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023

03/23 04:05 pm

Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference

02/08 05:05 pm

Eledon Pharmaceuticals Provides Business and Pipeline Updates

01/09 09:31 am

C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

12/21 05:05 pm

Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

11/03 04:05 pm

Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS

10/24 04:05 pm

Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference

09/22 04:05 pm

Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients

08/01 05:00 am

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06/10 04:05 pm

Penny Stocks To Buy Now? 4 To Watch This Week

05/31 09:49 am

Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

05/31 06:00 am

Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

05/05 04:05 pm

Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference

04/18 04:05 pm

Eledon to Host Virtual R&D Day on Thursday, April 28, 2022

04/14 04:05 pm

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results

03/24 04:01 pm

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

03/24 08:10 am

Eledon Pharmaceuticals to Participate in 11th Annual SVB Leerink Global Healthcare Conference

02/08 05:05 pm